2009 Conference
12th GERPAC Conference
7th European GERPAC
Sterile drugs preparation
Anticancer drugs – Monoclonal antibodies CIVAS
7th European GERPAC
Sterile drugs preparation
Anticancer drugs – Monoclonal antibodies CIVAS
October 7, 8 & 9 - Hyères - France
New design for cytotoxic treatments
New drug delivery systems for cytotoxic drugs
JP. Benoit
INSERM U 646, Angers University, France
Consequences of new delivery systems on drug preparation in hospitals
F. Lagarce
INSERM U 646,
CHU Angers, France
CHU Angers, France
Environmental cytotoxic contamination updating
Biological assessment of professional exposure to anti-cancer drugs in the hospital sector
S. Ndaw
INRS, Vandoeuvre-les -Nancy, France
Pollution of hospital waste with cytotoxic compounds
S. Zini
Agence Française de Sécurité Sanitaire de l’Environnement et du Travail (Afsset), Maisons-Alfort, France
External contamination of vials containing cytotoxins: simulated spread of contamination
S. Mosset1, G. Podilsky2, S. Maier2, L. Berger2, A. Pannatier1, 2
1 Ecole de pharmacie, Université de Lausanne et Genève, Genève, Suisse2 Service de pharmacie, Centre Hospitalier Universitaire du Vaudois, Lausanne, Suisse
Monoclonal antibodies preparation risk analysis
Classification of Hazardous Drugs by NIOSH
Thomas H. Connor
Division of Applied Research and Technology
National Institute for Occupational Safety and Health
Cincinnati, Ohio, USA Assessing the risk of handling monoclonal antibodies S. Langford Huddersfield Royal Infirmery, Huddersfield, UK A standardised assessment method for risk exposure and protective measures F. Sadeghipour, L.-Z. Kaestli Pharmacie des Hôpitaux Universitaires de Genève, Suisse
National Institute for Occupational Safety and Health
Cincinnati, Ohio, USA Assessing the risk of handling monoclonal antibodies S. Langford Huddersfield Royal Infirmery, Huddersfield, UK A standardised assessment method for risk exposure and protective measures F. Sadeghipour, L.-Z. Kaestli Pharmacie des Hôpitaux Universitaires de Genève, Suisse
Centralised Intravenous Additive Services (CIVAS)
CIVAS : Objectives and strategy
Pascal Bonnabry
Pharmacy, Geneva University Hospitals (HUG),
Section of pharmaceutical sciences, University of Geneva, University of Lausanne,
Geneva, Switzerland CIVAS, Current UK Practice and challenges A. Horton Plymouth Hospitals NHS Trust Freezing injectable preparations J.D. Hecq UCL Mont Godinne, Belgique
Section of pharmaceutical sciences, University of Geneva, University of Lausanne,
Geneva, Switzerland CIVAS, Current UK Practice and challenges A. Horton Plymouth Hospitals NHS Trust Freezing injectable preparations J.D. Hecq UCL Mont Godinne, Belgique
Short oral communications
The chemotherapy preparation cycle: establishing a patient information policy at Limoges University Hospital
A-L. Lepetit, A. Cournede, A-C. Danton, H. Carpenet, A. Lagarde
Pharmacie Centrale, UPA, CHU de Limoges, France
Monitoring the performance of preparation technicians with modified Media Fill Tests (MFTs)
E. Sigward, M. Fourgeaud, R. Vazquez, M-N. Guerrault-Moro, D. Brossard, S. Crauste-Manciet
Centre Hospitalier Intercommunal Poissy - St Germain en Laye, site St Germain en Laye, France
Developing an assessment system for pharmacotechnical personnel
K. Balsam1, E. Ledru2
1 Centre Hospitalier de Saint-Denis, Service de Pharmacie, Saint Denis, France
2 E. Ledru - Centre Hospitalier d’Orsay, Service de Pharmacie Orsay, France Determining the effectiveness of a training module for use of the Multispec spectrophotometer to judge the dosage of injectable anti-cancer medicines A. Camut, V. Noirez, A. Khalifé Pharmacie Hôpital Bon Secours, Metz, France Implementing a training and evaluation procedure for preparation technicians joining Clinical Research Units (CRUs) M. Lefebvre, M. Rossignol, P. Hild, F. Cabrera, C. Niepceron Pharmacie, Centre Hospitalier de Roanne, France Preparation of cytotoxic products in the Nord-Pas-de-Calais region: In line or not in line with Good Preparation Practice guidelines, that is the question! A. Dewailly, C. Rousselière, C. Fournier Service Pharmacie médicaments, Centre hospitalier de Lens, France Fine-tuning and operational testing of the prototype Cytotoxic Formulation Machine (CFM), an automated cytotoxic preparation system A. Hurgon, C. Giard, L. Escalup Institut Curie, service Pharmacie, France The benefits of automation of the preparation of anti-cancer medicines M. Bay, E. Chasseuil, A. Dupuis, I. Princet Pharmacie du CHU Poitiers, France Can Trisenox® be prepared in the same way as other anti-cancer drugs? C. Combis, J-N. Visbecq, H. Beaussart, V. Calmels, F. Danicourt, J-P. Résibois Centre Hospitalier de Dunkerque, France Sécurisation du circuit du médicament : bilan d’une interface entre un logiciel de prescription pédiatrique Poséidon et Chimio® S. Philippe1, V. Solans1, A. Coquard1, B. Dieu1, J.P. Vannier2 1 Pôle Pharmacie
2 Paediatric Haematology-Oncology department, CHU de Rouen, France Practical evaluation of 5 portable diffusers used in anti-cancer chemotherapy: the benefits of using the ‘bootstrap’ method to interpret the results G. Herbin1, C. Pobel1, E. Kiep1, F. Borde2 1 Pharmacie, CH Saintonge, Saintes, France
2 Oncologie, CH Saintonge, Saintes, France A dose standardisation experiment: Application to monoclonal antibodies O. Kaatz, C. Lemarignier, M. Ancel, D. Roncalez Service Pharmacie, Hôpitaux Civils de Colmar, France Analysing the feasibility of performing release authorisation tests on cytotoxic preparations using video capture B. Le Franc , P. Chauvet, E. Griesemann, J-P. Cante Pharmacie, CH La Rochelle, France Advantages and limitations of IRTF-UV analysis MP. Kuzzay, A. Maire, C. Bousquet, R. Respaud, J-F. Tournamille, D. Antier UBCO, Pharmacie Bretonneau, CHRU de Tours, France Raman Spectroscopy: an ultra-rapid and non-destructive solution for Analytical Quality Control of injectable solutions, and its application to oxazaphosphorins Bruno Cassard1, Rozenn Clément1, Patrice Prognon2, Philippe Bourget1 1 Service de Pharmacie Clinique, Hôpital Necker - Enfants Malades
2 Service de Pharmacie Clinique, Hôpital Européen Georges Pompidou, France
2 E. Ledru - Centre Hospitalier d’Orsay, Service de Pharmacie Orsay, France Determining the effectiveness of a training module for use of the Multispec spectrophotometer to judge the dosage of injectable anti-cancer medicines A. Camut, V. Noirez, A. Khalifé Pharmacie Hôpital Bon Secours, Metz, France Implementing a training and evaluation procedure for preparation technicians joining Clinical Research Units (CRUs) M. Lefebvre, M. Rossignol, P. Hild, F. Cabrera, C. Niepceron Pharmacie, Centre Hospitalier de Roanne, France Preparation of cytotoxic products in the Nord-Pas-de-Calais region: In line or not in line with Good Preparation Practice guidelines, that is the question! A. Dewailly, C. Rousselière, C. Fournier Service Pharmacie médicaments, Centre hospitalier de Lens, France Fine-tuning and operational testing of the prototype Cytotoxic Formulation Machine (CFM), an automated cytotoxic preparation system A. Hurgon, C. Giard, L. Escalup Institut Curie, service Pharmacie, France The benefits of automation of the preparation of anti-cancer medicines M. Bay, E. Chasseuil, A. Dupuis, I. Princet Pharmacie du CHU Poitiers, France Can Trisenox® be prepared in the same way as other anti-cancer drugs? C. Combis, J-N. Visbecq, H. Beaussart, V. Calmels, F. Danicourt, J-P. Résibois Centre Hospitalier de Dunkerque, France Sécurisation du circuit du médicament : bilan d’une interface entre un logiciel de prescription pédiatrique Poséidon et Chimio® S. Philippe1, V. Solans1, A. Coquard1, B. Dieu1, J.P. Vannier2 1 Pôle Pharmacie
2 Paediatric Haematology-Oncology department, CHU de Rouen, France Practical evaluation of 5 portable diffusers used in anti-cancer chemotherapy: the benefits of using the ‘bootstrap’ method to interpret the results G. Herbin1, C. Pobel1, E. Kiep1, F. Borde2 1 Pharmacie, CH Saintonge, Saintes, France
2 Oncologie, CH Saintonge, Saintes, France A dose standardisation experiment: Application to monoclonal antibodies O. Kaatz, C. Lemarignier, M. Ancel, D. Roncalez Service Pharmacie, Hôpitaux Civils de Colmar, France Analysing the feasibility of performing release authorisation tests on cytotoxic preparations using video capture B. Le Franc , P. Chauvet, E. Griesemann, J-P. Cante Pharmacie, CH La Rochelle, France Advantages and limitations of IRTF-UV analysis MP. Kuzzay, A. Maire, C. Bousquet, R. Respaud, J-F. Tournamille, D. Antier UBCO, Pharmacie Bretonneau, CHRU de Tours, France Raman Spectroscopy: an ultra-rapid and non-destructive solution for Analytical Quality Control of injectable solutions, and its application to oxazaphosphorins Bruno Cassard1, Rozenn Clément1, Patrice Prognon2, Philippe Bourget1 1 Service de Pharmacie Clinique, Hôpital Necker - Enfants Malades
2 Service de Pharmacie Clinique, Hôpital Européen Georges Pompidou, France